Frontpage Slideshow | Copyright © 2006-2011 JoomlaWorks Ltd.

Get in touch

1800 437 222

Viral hepatitis (A, B & C)

Hepatitis means inflammation of the liver, and it can be caused by a virus or other non-viral causes.  The main difference between the viruses is how they are spread and the effects they have on your health.

Read more...

Prevention

There are safe and effective vaccines that protect you from getting hepatitis A and B.  While there is no vaccine for hep C, by being ‘blood aware’ you can reduce your overall chance of being exposed to the virus.

Read more...

Living with Hepatitis

People with chronic hepatitis can do a number of things to stay healthy including limiting/avoiding alcohol, reducing stress, not smoking, getting regular exercise and eating a healthy diet.

Read more...

Treatment

Effective treatment is available for both chronic hepatitis B and C.  Before you can see a liver specialist to talk about going on treatment, you need to get a referral from your GP first.

Read more...
ContentViewArticle Object
(
    [item:protected] => stdClass Object
        (
            [id] => 90
            [asset_id] => 132
            [title] => Strategies and Policies
            [alias] => strategies-and-policies
            [title_alias] => 
            [introtext] => 

 

2014
 

National Hep C Strategy

The Fourth National Hepatitis C Virus (HCV) Strategy 2014-2017. This is one of five strategies aiming to reduce sexually transmissible infections (STI) and blood borne viruses (BBV), and the morbidity, mortality and personal and social impacts they cause. Developed by the Commonwealth of Australia.

2014
 

National Hep B Strategy

The Second National Hepatitis B Strategy 2014-2017. Developed by the Commonwealth of Australia.

2014
 

National Aboriginal Torres Strait Islander Blood Borne Virus Strategy

The Fourth National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2014-2017. Developed by the Commonwealth of Australia.

2010
 

National Hep C Strategy - 110KB PDF

Third National Hepatitis C Strategy 2010-2013.  This is the third national hep C strategy to be adopted in Australia. It builds on two previous strategies which guided Australia’s response to hep C between 1999 and 2008. Developed by the Commonwealth Department of Health and Ageing.

2010
 

National Hep B Strategy - 80KB PDF

National Hepatitis B Strategy 2010-2013. This is the first hep B strategy to be adopted in Australia. Developed by the Commonwealth Department of Health and Ageing.

2010
 

National Aboriginal Torres Strait Islander Blood Borne Virus Strategy - 150KB PDF

Third National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2010–2013. The third National Aboriginal and Torres Strait Islander Strategy dealing with blood borne viruses and sexually transmissible infections (STIs) to be adopted in Australia.

2010  

Hepatitis C Models of Access and Service Delivery for People with a History of Injecting Drug Use - 804KB PDF

"Research evidence reflects that in Australia unsafe injecting practices account for almost 80 percent of all current hepatitis C infections and over 90 percent of all new infections (Razali, 2007). While this evidence highlights the importance of focusing on strategies to prevent the further transmission of hepatitis C among people who inject drugs, the high rates of current infection also emphasise the urgent need to focus on the development of appropriate models of access and service delivery for people with hepatitis C and a history of injecting drug use. The need for more appropriate and targeted models of access and service delivery is further highlighted by the fact that 75 percent of people infected with hepatitis C will develop chronic infection (NCHECR, 2009a)." By Australian Injecting and Illicit Drug Users League (AIVL) October 2010.

2009  

 Strategic Directions for HIV/AIDS, Hepatitis C and Sexual Health 2009 - 2012 - 557KB  PDF

This document identifies priority actions for addressing HIV, HCV and STIs between 2009-2012. Published by Queensland Health.

2008
 

Guidelines for hep C prevention, treatment and care in Australian prisons - 300KB PDF

Hepatitis C Prevention, Treatment and Care: Guidelines for Australian Custodial Settings. These Guidelines and their Evidence-Base have been developed by the Prisons Working Group of the Hepatitis C Subcommittee of the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis (MACASHH) for the prevention, treatment and care of hepatitis C in custodial settings. The guiding principles for this document have been adopted from the National Hepatitis C Strategy 2005-2008.  

 
2008
 

Guidelines for hep C prevention, treatment and care in Australian prisons (the evidence base) - 300KB PDF

Hepatitis C Prevention, Treatment and Care: Guidelines for Australian Custodial Settings: Evidence base for the guidelines. This document explains the evidence base for the guidelines for the prevention, treatment and care of hepatitis C in custodial settings. It has been developed, at the same time as the guidelines, by the Prisons Working Group of the Hepatitis C Subcommittee of the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis. 

 
2007  

Hepatitis Council of Queensland Strategic Plan 2007-2010 - 327KB PDF

Published by Hepatitis Queensland (previously the Hepatitis Council of Queensland), this document outlines HQ's 2007-2010 plan to 'provide holistic, innovative and pro-active responses to the challenges confronting people directly and indirectly affected by viral hepatitis'.

2007
 

National Hepatitis C Testing Policy - 300KB PDF

National Hepatitis C Testing Policy. Published by the Commonwealth Department of Health & Ageing Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis, and the Australian Population Health Development Principal Committee. This document provides policy on testing for hepatitis C,  monitoring the clinical condition of people before, during and after treatment for hepatitis C and screening the blood supply.

2006
 

Hepatitis B in Australia - 2MB PDF

Hepatitis B in Australia: responding to a diverse epidemic. Published by ACT-HBV, this report was authored by Greg Dore, Jack Wallace and others. This document aims to raise public awareness of hepatitis B, develop advocacy for a national strategy and provide a platform for developing a concerted public health approach to hepatitis B.

2005  

Queensland HIV, Hepatitis C and Sexually Transmissible Infections Strategy 2005–2011 - 858KB PDF

"The purpose of the Strategy is to provide direction and a framework for cooperation and support for and between government and non-government agencies, private practitioners, research organisations, service providers, community groups and the wider community to work together to: reduce the transmission of HIV, HCV and STIs, minimise the impact of HIV, HCV and STIs on the Queensland population; and improve the health and wellbeing of people living with HIV, HCV and STI-related chronic illness." Published by Queensland Health.

Some info republished here with permission from Hepatitis NSW.


 

[fulltext] => [state] => 1 [mask] => 0 [catid] => 7 [created] => 2010-11-09 05:11:00 [created_by] => 66 [created_by_alias] => [modified] => 2014-08-04 01:18:07 [modified_by] => 66 [checked_out] => 66 [checked_out_time] => 2014-08-04 01:18:07 [publish_up] => 2010-11-09 05:11:00 [publish_down] => 0000-00-00 00:00:00 [images] => [urls] => [attribs] => {"show_title":"","link_titles":"","show_intro":"","show_category":"","link_category":"","show_parent_category":"","link_parent_category":"","show_author":"","link_author":"","show_create_date":"","show_modify_date":"","show_publish_date":"","show_item_navigation":"","show_icons":"","show_print_icon":"","show_email_icon":"","show_vote":"","show_hits":"","show_noauth":"","urls_position":"","alternative_readmore":"","article_layout":"","show_publishing_options":"","show_article_options":"","show_urls_images_backend":"","show_urls_images_frontend":""} [version] => 37 [parentid] => 0 [ordering] => 5 [metakey] => [metadesc] => [access] => 1 [hits] => 13920 [metadata] => JRegistry Object ( [data:protected] => stdClass Object ( [robots] => [author] => [rights] => [xreference] => ) ) [featured] => 0 [language] => * [xreference] => [category_title] => Menu pages [category_alias] => menu-pages [category_access] => 1 [author] => Hepatitis Admin [contactid] => [parent_title] => General [parent_id] => 15 [parent_route] => general [parent_alias] => general [rating] => [rating_count] => [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 1 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 1 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 1 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 0 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => right [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 0 [show_category_title] => 0 [show_description] => 0 [show_description_image] => 0 [maxLevel] => -1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 1 [show_base_description] => 0 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 1 [num_intro_articles] => 4 [num_columns] => 2 [num_links] => 4 [multi_column_order] => 0 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => none [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [show_page_title] => 1 [secure] => 0 [show_page_heading] => 0 [page_title] => Strategies and Policies [page_description] => Hepatitis Queensland [page_rights] => [robots] => [access-view] => 1 ) ) [slug] => 90:strategies-and-policies [catslug] => 7:menu-pages [parent_slug] => 15:general [readmore_link] => /information/strategies-and-policies [text] =>

 

2014
 

National Hep C Strategy

The Fourth National Hepatitis C Virus (HCV) Strategy 2014-2017. This is one of five strategies aiming to reduce sexually transmissible infections (STI) and blood borne viruses (BBV), and the morbidity, mortality and personal and social impacts they cause. Developed by the Commonwealth of Australia.

2014
 

National Hep B Strategy

The Second National Hepatitis B Strategy 2014-2017. Developed by the Commonwealth of Australia.

2014
 

National Aboriginal Torres Strait Islander Blood Borne Virus Strategy

The Fourth National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2014-2017. Developed by the Commonwealth of Australia.

2010
 

National Hep C Strategy - 110KB PDF

Third National Hepatitis C Strategy 2010-2013.  This is the third national hep C strategy to be adopted in Australia. It builds on two previous strategies which guided Australia’s response to hep C between 1999 and 2008. Developed by the Commonwealth Department of Health and Ageing.

2010
 

National Hep B Strategy - 80KB PDF

National Hepatitis B Strategy 2010-2013. This is the first hep B strategy to be adopted in Australia. Developed by the Commonwealth Department of Health and Ageing.

2010
 

National Aboriginal Torres Strait Islander Blood Borne Virus Strategy - 150KB PDF

Third National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2010–2013. The third National Aboriginal and Torres Strait Islander Strategy dealing with blood borne viruses and sexually transmissible infections (STIs) to be adopted in Australia.

2010  

Hepatitis C Models of Access and Service Delivery for People with a History of Injecting Drug Use - 804KB PDF

"Research evidence reflects that in Australia unsafe injecting practices account for almost 80 percent of all current hepatitis C infections and over 90 percent of all new infections (Razali, 2007). While this evidence highlights the importance of focusing on strategies to prevent the further transmission of hepatitis C among people who inject drugs, the high rates of current infection also emphasise the urgent need to focus on the development of appropriate models of access and service delivery for people with hepatitis C and a history of injecting drug use. The need for more appropriate and targeted models of access and service delivery is further highlighted by the fact that 75 percent of people infected with hepatitis C will develop chronic infection (NCHECR, 2009a)." By Australian Injecting and Illicit Drug Users League (AIVL) October 2010.

2009  

 Strategic Directions for HIV/AIDS, Hepatitis C and Sexual Health 2009 - 2012 - 557KB  PDF

This document identifies priority actions for addressing HIV, HCV and STIs between 2009-2012. Published by Queensland Health.

2008
 

Guidelines for hep C prevention, treatment and care in Australian prisons - 300KB PDF

Hepatitis C Prevention, Treatment and Care: Guidelines for Australian Custodial Settings. These Guidelines and their Evidence-Base have been developed by the Prisons Working Group of the Hepatitis C Subcommittee of the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis (MACASHH) for the prevention, treatment and care of hepatitis C in custodial settings. The guiding principles for this document have been adopted from the National Hepatitis C Strategy 2005-2008.  

 
2008
 

Guidelines for hep C prevention, treatment and care in Australian prisons (the evidence base) - 300KB PDF

Hepatitis C Prevention, Treatment and Care: Guidelines for Australian Custodial Settings: Evidence base for the guidelines. This document explains the evidence base for the guidelines for the prevention, treatment and care of hepatitis C in custodial settings. It has been developed, at the same time as the guidelines, by the Prisons Working Group of the Hepatitis C Subcommittee of the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis. 

 
2007  

Hepatitis Council of Queensland Strategic Plan 2007-2010 - 327KB PDF

Published by Hepatitis Queensland (previously the Hepatitis Council of Queensland), this document outlines HQ's 2007-2010 plan to 'provide holistic, innovative and pro-active responses to the challenges confronting people directly and indirectly affected by viral hepatitis'.

2007
 

National Hepatitis C Testing Policy - 300KB PDF

National Hepatitis C Testing Policy. Published by the Commonwealth Department of Health & Ageing Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis, and the Australian Population Health Development Principal Committee. This document provides policy on testing for hepatitis C,  monitoring the clinical condition of people before, during and after treatment for hepatitis C and screening the blood supply.

2006
 

Hepatitis B in Australia - 2MB PDF

Hepatitis B in Australia: responding to a diverse epidemic. Published by ACT-HBV, this report was authored by Greg Dore, Jack Wallace and others. This document aims to raise public awareness of hepatitis B, develop advocacy for a national strategy and provide a platform for developing a concerted public health approach to hepatitis B.

2005  

Queensland HIV, Hepatitis C and Sexually Transmissible Infections Strategy 2005–2011 - 858KB PDF

"The purpose of the Strategy is to provide direction and a framework for cooperation and support for and between government and non-government agencies, private practitioners, research organisations, service providers, community groups and the wider community to work together to: reduce the transmission of HIV, HCV and STIs, minimise the impact of HIV, HCV and STIs on the Queensland population; and improve the health and wellbeing of people living with HIV, HCV and STI-related chronic illness." Published by Queensland Health.

Some info republished here with permission from Hepatitis NSW.


 

[event] => stdClass Object ( [afterDisplayTitle] => [beforeDisplayContent] => [afterDisplayContent] => ) ) [params:protected] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 1 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 1 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 1 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 0 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => right [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 0 [show_category_title] => 0 [show_description] => 0 [show_description_image] => 0 [maxLevel] => -1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 1 [show_base_description] => 0 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 1 [num_intro_articles] => 4 [num_columns] => 2 [num_links] => 4 [multi_column_order] => 0 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => none [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [show_page_title] => 1 [secure] => 0 [show_page_heading] => 0 [page_title] => Strategies and Policies [page_description] => Hepatitis Queensland [page_rights] => [robots] => [page_heading] => Strategies and Policies ) ) [print:protected] => [state:protected] => JObject Object ( [_errors:protected] => Array ( ) [task] => [parameters.menu] => JRegistry Object ( [data:protected] => stdClass Object ( [show_noauth] => [show_title] => [link_titles] => [show_intro] => [show_section] => [link_section] => [show_category] => [link_category] => [show_author] => [show_create_date] => [show_modify_date] => [show_item_navigation] => [show_readmore] => [show_vote] => [show_icons] => [show_pdf_icon] => [show_print_icon] => [show_email_icon] => [show_hits] => [feed_summary] => [page_title] => [show_page_title] => 1 [pageclass_sfx] => [menu_image] => [secure] => 0 [show_page_heading] => 0 ) ) [article.id] => 90 [list.offset] => 0 [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 1 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 1 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 1 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 0 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => right [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 0 [show_category_title] => 0 [show_description] => 0 [show_description_image] => 0 [maxLevel] => -1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 1 [show_base_description] => 0 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 1 [num_intro_articles] => 4 [num_columns] => 2 [num_links] => 4 [multi_column_order] => 0 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => none [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [show_page_title] => 1 [secure] => 0 [show_page_heading] => 0 [page_title] => Strategies and Policies [page_description] => Hepatitis Queensland [page_rights] => [robots] => [page_heading] => Strategies and Policies ) ) [filter.published] => 1 [filter.archived] => 2 [filter.language] => ) [user:protected] => JUser Object ( [isRoot:protected] => [id] => 0 [name] => [username] => [email] => [password] => [password_clear] => [usertype] => [block] => [sendEmail] => 0 [registerDate] => [lastvisitDate] => [activation] => [params] => [groups] => Array ( ) [guest] => 1 [lastResetTime] => [resetCount] => [_params:protected] => JRegistry Object ( [data:protected] => stdClass Object ( ) ) [_authGroups:protected] => Array ( [0] => 1 ) [_authLevels:protected] => Array ( [0] => 1 [1] => 1 ) [_authActions:protected] => [_errorMsg:protected] => [_errors:protected] => Array ( ) [aid] => 0 ) [_name:protected] => article [_models:protected] => Array ( [article] => ContentModelArticle Object ( [_context:protected] => com_content.article [_item:protected] => Array ( [90] => stdClass Object ( [id] => 90 [asset_id] => 132 [title] => Strategies and Policies [alias] => strategies-and-policies [title_alias] => [introtext] =>

 

2014
 

National Hep C Strategy

The Fourth National Hepatitis C Virus (HCV) Strategy 2014-2017. This is one of five strategies aiming to reduce sexually transmissible infections (STI) and blood borne viruses (BBV), and the morbidity, mortality and personal and social impacts they cause. Developed by the Commonwealth of Australia.

2014
 

National Hep B Strategy

The Second National Hepatitis B Strategy 2014-2017. Developed by the Commonwealth of Australia.

2014
 

National Aboriginal Torres Strait Islander Blood Borne Virus Strategy

The Fourth National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2014-2017. Developed by the Commonwealth of Australia.

2010
 

National Hep C Strategy - 110KB PDF

Third National Hepatitis C Strategy 2010-2013.  This is the third national hep C strategy to be adopted in Australia. It builds on two previous strategies which guided Australia’s response to hep C between 1999 and 2008. Developed by the Commonwealth Department of Health and Ageing.

2010
 

National Hep B Strategy - 80KB PDF

National Hepatitis B Strategy 2010-2013. This is the first hep B strategy to be adopted in Australia. Developed by the Commonwealth Department of Health and Ageing.

2010
 

National Aboriginal Torres Strait Islander Blood Borne Virus Strategy - 150KB PDF

Third National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2010–2013. The third National Aboriginal and Torres Strait Islander Strategy dealing with blood borne viruses and sexually transmissible infections (STIs) to be adopted in Australia.

2010  

Hepatitis C Models of Access and Service Delivery for People with a History of Injecting Drug Use - 804KB PDF

"Research evidence reflects that in Australia unsafe injecting practices account for almost 80 percent of all current hepatitis C infections and over 90 percent of all new infections (Razali, 2007). While this evidence highlights the importance of focusing on strategies to prevent the further transmission of hepatitis C among people who inject drugs, the high rates of current infection also emphasise the urgent need to focus on the development of appropriate models of access and service delivery for people with hepatitis C and a history of injecting drug use. The need for more appropriate and targeted models of access and service delivery is further highlighted by the fact that 75 percent of people infected with hepatitis C will develop chronic infection (NCHECR, 2009a)." By Australian Injecting and Illicit Drug Users League (AIVL) October 2010.

2009  

 Strategic Directions for HIV/AIDS, Hepatitis C and Sexual Health 2009 - 2012 - 557KB  PDF

This document identifies priority actions for addressing HIV, HCV and STIs between 2009-2012. Published by Queensland Health.

2008
 

Guidelines for hep C prevention, treatment and care in Australian prisons - 300KB PDF

Hepatitis C Prevention, Treatment and Care: Guidelines for Australian Custodial Settings. These Guidelines and their Evidence-Base have been developed by the Prisons Working Group of the Hepatitis C Subcommittee of the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis (MACASHH) for the prevention, treatment and care of hepatitis C in custodial settings. The guiding principles for this document have been adopted from the National Hepatitis C Strategy 2005-2008.  

 
2008
 

Guidelines for hep C prevention, treatment and care in Australian prisons (the evidence base) - 300KB PDF

Hepatitis C Prevention, Treatment and Care: Guidelines for Australian Custodial Settings: Evidence base for the guidelines. This document explains the evidence base for the guidelines for the prevention, treatment and care of hepatitis C in custodial settings. It has been developed, at the same time as the guidelines, by the Prisons Working Group of the Hepatitis C Subcommittee of the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis. 

 
2007  

Hepatitis Council of Queensland Strategic Plan 2007-2010 - 327KB PDF

Published by Hepatitis Queensland (previously the Hepatitis Council of Queensland), this document outlines HQ's 2007-2010 plan to 'provide holistic, innovative and pro-active responses to the challenges confronting people directly and indirectly affected by viral hepatitis'.

2007
 

National Hepatitis C Testing Policy - 300KB PDF

National Hepatitis C Testing Policy. Published by the Commonwealth Department of Health & Ageing Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis, and the Australian Population Health Development Principal Committee. This document provides policy on testing for hepatitis C,  monitoring the clinical condition of people before, during and after treatment for hepatitis C and screening the blood supply.

2006
 

Hepatitis B in Australia - 2MB PDF

Hepatitis B in Australia: responding to a diverse epidemic. Published by ACT-HBV, this report was authored by Greg Dore, Jack Wallace and others. This document aims to raise public awareness of hepatitis B, develop advocacy for a national strategy and provide a platform for developing a concerted public health approach to hepatitis B.

2005  

Queensland HIV, Hepatitis C and Sexually Transmissible Infections Strategy 2005–2011 - 858KB PDF

"The purpose of the Strategy is to provide direction and a framework for cooperation and support for and between government and non-government agencies, private practitioners, research organisations, service providers, community groups and the wider community to work together to: reduce the transmission of HIV, HCV and STIs, minimise the impact of HIV, HCV and STIs on the Queensland population; and improve the health and wellbeing of people living with HIV, HCV and STI-related chronic illness." Published by Queensland Health.

Some info republished here with permission from Hepatitis NSW.


 

[fulltext] => [state] => 1 [mask] => 0 [catid] => 7 [created] => 2010-11-09 05:11:00 [created_by] => 66 [created_by_alias] => [modified] => 2014-08-04 01:18:07 [modified_by] => 66 [checked_out] => 66 [checked_out_time] => 2014-08-04 01:18:07 [publish_up] => 2010-11-09 05:11:00 [publish_down] => 0000-00-00 00:00:00 [images] => [urls] => [attribs] => {"show_title":"","link_titles":"","show_intro":"","show_category":"","link_category":"","show_parent_category":"","link_parent_category":"","show_author":"","link_author":"","show_create_date":"","show_modify_date":"","show_publish_date":"","show_item_navigation":"","show_icons":"","show_print_icon":"","show_email_icon":"","show_vote":"","show_hits":"","show_noauth":"","urls_position":"","alternative_readmore":"","article_layout":"","show_publishing_options":"","show_article_options":"","show_urls_images_backend":"","show_urls_images_frontend":""} [version] => 37 [parentid] => 0 [ordering] => 5 [metakey] => [metadesc] => [access] => 1 [hits] => 13920 [metadata] => JRegistry Object ( [data:protected] => stdClass Object ( [robots] => [author] => [rights] => [xreference] => ) ) [featured] => 0 [language] => * [xreference] => [category_title] => Menu pages [category_alias] => menu-pages [category_access] => 1 [author] => Hepatitis Admin [contactid] => [parent_title] => General [parent_id] => 15 [parent_route] => general [parent_alias] => general [rating] => [rating_count] => [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 1 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 1 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 1 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 0 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => right [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 0 [show_category_title] => 0 [show_description] => 0 [show_description_image] => 0 [maxLevel] => -1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 1 [show_base_description] => 0 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 1 [num_intro_articles] => 4 [num_columns] => 2 [num_links] => 4 [multi_column_order] => 0 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => none [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [show_page_title] => 1 [secure] => 0 [show_page_heading] => 0 [page_title] => Strategies and Policies [page_description] => Hepatitis Queensland [page_rights] => [robots] => [access-view] => 1 ) ) [slug] => 90:strategies-and-policies [catslug] => 7:menu-pages [parent_slug] => 15:general [readmore_link] => /information/strategies-and-policies [text] =>

 

2014
 

National Hep C Strategy

The Fourth National Hepatitis C Virus (HCV) Strategy 2014-2017. This is one of five strategies aiming to reduce sexually transmissible infections (STI) and blood borne viruses (BBV), and the morbidity, mortality and personal and social impacts they cause. Developed by the Commonwealth of Australia.

2014
 

National Hep B Strategy

The Second National Hepatitis B Strategy 2014-2017. Developed by the Commonwealth of Australia.

2014
 

National Aboriginal Torres Strait Islander Blood Borne Virus Strategy

The Fourth National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2014-2017. Developed by the Commonwealth of Australia.

2010
 

National Hep C Strategy - 110KB PDF

Third National Hepatitis C Strategy 2010-2013.  This is the third national hep C strategy to be adopted in Australia. It builds on two previous strategies which guided Australia’s response to hep C between 1999 and 2008. Developed by the Commonwealth Department of Health and Ageing.

2010
 

National Hep B Strategy - 80KB PDF

National Hepatitis B Strategy 2010-2013. This is the first hep B strategy to be adopted in Australia. Developed by the Commonwealth Department of Health and Ageing.

2010
 

National Aboriginal Torres Strait Islander Blood Borne Virus Strategy - 150KB PDF

Third National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2010–2013. The third National Aboriginal and Torres Strait Islander Strategy dealing with blood borne viruses and sexually transmissible infections (STIs) to be adopted in Australia.

2010  

Hepatitis C Models of Access and Service Delivery for People with a History of Injecting Drug Use - 804KB PDF

"Research evidence reflects that in Australia unsafe injecting practices account for almost 80 percent of all current hepatitis C infections and over 90 percent of all new infections (Razali, 2007). While this evidence highlights the importance of focusing on strategies to prevent the further transmission of hepatitis C among people who inject drugs, the high rates of current infection also emphasise the urgent need to focus on the development of appropriate models of access and service delivery for people with hepatitis C and a history of injecting drug use. The need for more appropriate and targeted models of access and service delivery is further highlighted by the fact that 75 percent of people infected with hepatitis C will develop chronic infection (NCHECR, 2009a)." By Australian Injecting and Illicit Drug Users League (AIVL) October 2010.

2009  

 Strategic Directions for HIV/AIDS, Hepatitis C and Sexual Health 2009 - 2012 - 557KB  PDF

This document identifies priority actions for addressing HIV, HCV and STIs between 2009-2012. Published by Queensland Health.

2008
 

Guidelines for hep C prevention, treatment and care in Australian prisons - 300KB PDF

Hepatitis C Prevention, Treatment and Care: Guidelines for Australian Custodial Settings. These Guidelines and their Evidence-Base have been developed by the Prisons Working Group of the Hepatitis C Subcommittee of the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis (MACASHH) for the prevention, treatment and care of hepatitis C in custodial settings. The guiding principles for this document have been adopted from the National Hepatitis C Strategy 2005-2008.  

 
2008
 

Guidelines for hep C prevention, treatment and care in Australian prisons (the evidence base) - 300KB PDF

Hepatitis C Prevention, Treatment and Care: Guidelines for Australian Custodial Settings: Evidence base for the guidelines. This document explains the evidence base for the guidelines for the prevention, treatment and care of hepatitis C in custodial settings. It has been developed, at the same time as the guidelines, by the Prisons Working Group of the Hepatitis C Subcommittee of the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis. 

 
2007  

Hepatitis Council of Queensland Strategic Plan 2007-2010 - 327KB PDF

Published by Hepatitis Queensland (previously the Hepatitis Council of Queensland), this document outlines HQ's 2007-2010 plan to 'provide holistic, innovative and pro-active responses to the challenges confronting people directly and indirectly affected by viral hepatitis'.

2007
 

National Hepatitis C Testing Policy - 300KB PDF

National Hepatitis C Testing Policy. Published by the Commonwealth Department of Health & Ageing Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis, and the Australian Population Health Development Principal Committee. This document provides policy on testing for hepatitis C,  monitoring the clinical condition of people before, during and after treatment for hepatitis C and screening the blood supply.

2006
 

Hepatitis B in Australia - 2MB PDF

Hepatitis B in Australia: responding to a diverse epidemic. Published by ACT-HBV, this report was authored by Greg Dore, Jack Wallace and others. This document aims to raise public awareness of hepatitis B, develop advocacy for a national strategy and provide a platform for developing a concerted public health approach to hepatitis B.

2005  

Queensland HIV, Hepatitis C and Sexually Transmissible Infections Strategy 2005–2011 - 858KB PDF

"The purpose of the Strategy is to provide direction and a framework for cooperation and support for and between government and non-government agencies, private practitioners, research organisations, service providers, community groups and the wider community to work together to: reduce the transmission of HIV, HCV and STIs, minimise the impact of HIV, HCV and STIs on the Queensland population; and improve the health and wellbeing of people living with HIV, HCV and STI-related chronic illness." Published by Queensland Health.

Some info republished here with permission from Hepatitis NSW.


 

[event] => stdClass Object ( [afterDisplayTitle] => [beforeDisplayContent] => [afterDisplayContent] => ) ) ) [__state_set:protected] => 1 [_db:protected] => JDatabaseMySQLi Object ( [name] => mysqli [nameQuote:protected] => ` [nullDate:protected] => 0000-00-00 00:00:00 [dbMinimum:protected] => 5.0.4 [_database:JDatabase:private] => hepqld_joomla [connection:protected] => mysqli Object ( [affected_rows] => 1 [client_info] => 5.6.21 [client_version] => 50621 [connect_errno] => 0 [connect_error] => [errno] => 0 [error] => [field_count] => 0 [host_info] => Localhost via UNIX socket [info] => Rows matched: 1 Changed: 1 Warnings: 0 [insert_id] => 0 [server_info] => 5.6.21-log [server_version] => 50621 [stat] => Uptime: 1523525 Threads: 5 Questions: 455660350 Slow queries: 145700 Opens: 6574587 Flush tables: 1 Open tables: 2000 Queries per second avg: 299.082 [sqlstate] => 00000 [protocol_version] => 10 [thread_id] => 3152811 [warning_count] => 0 ) [count:protected] => 0 [cursor:protected] => 1 [debug:protected] => [limit:protected] => 0 [log:protected] => Array ( ) [offset:protected] => 0 [sql:protected] => UPDATE #__content SET hits = hits + 1 WHERE id = 90 [tablePrefix:protected] => j25_ [utf:protected] => 1 [errorNum:protected] => 0 [errorMsg:protected] => [hasQuoted:protected] => [quoted:protected] => Array ( ) ) [name:protected] => article [option:protected] => com_content [state:protected] => JObject Object ( [_errors:protected] => Array ( ) [task] => [parameters.menu] => JRegistry Object ( [data:protected] => stdClass Object ( [show_noauth] => [show_title] => [link_titles] => [show_intro] => [show_section] => [link_section] => [show_category] => [link_category] => [show_author] => [show_create_date] => [show_modify_date] => [show_item_navigation] => [show_readmore] => [show_vote] => [show_icons] => [show_pdf_icon] => [show_print_icon] => [show_email_icon] => [show_hits] => [feed_summary] => [page_title] => [show_page_title] => 1 [pageclass_sfx] => [menu_image] => [secure] => 0 [show_page_heading] => 0 ) ) [article.id] => 90 [list.offset] => 0 [params] => JRegistry Object ( [data:protected] => stdClass Object ( [article_layout] => _:default [show_title] => 1 [link_titles] => 0 [show_intro] => 1 [show_category] => 0 [link_category] => 0 [show_parent_category] => 0 [link_parent_category] => 1 [show_author] => 0 [link_author] => 0 [show_create_date] => 0 [show_modify_date] => 0 [show_publish_date] => 0 [show_item_navigation] => 0 [show_vote] => 0 [show_readmore] => 1 [show_readmore_title] => 1 [readmore_limit] => 100 [show_icons] => 0 [show_print_icon] => 0 [show_email_icon] => 0 [show_hits] => 0 [show_noauth] => 0 [urls_position] => 0 [show_publishing_options] => 1 [show_article_options] => 1 [show_urls_images_frontend] => 0 [show_urls_images_backend] => 0 [targeta] => 0 [targetb] => 0 [targetc] => 0 [float_intro] => right [float_fulltext] => right [category_layout] => _:blog [show_category_heading_title_text] => 0 [show_category_title] => 0 [show_description] => 0 [show_description_image] => 0 [maxLevel] => -1 [show_empty_categories] => 0 [show_no_articles] => 1 [show_subcat_desc] => 1 [show_cat_num_articles] => 1 [show_base_description] => 0 [maxLevelcat] => -1 [show_empty_categories_cat] => 0 [show_subcat_desc_cat] => 1 [show_cat_num_articles_cat] => 1 [num_leading_articles] => 1 [num_intro_articles] => 4 [num_columns] => 2 [num_links] => 4 [multi_column_order] => 0 [show_subcategory_content] => 0 [show_pagination_limit] => 1 [filter_field] => hide [show_headings] => 1 [list_show_date] => 0 [date_format] => [list_show_hits] => 1 [list_show_author] => 1 [orderby_pri] => none [orderby_sec] => rdate [order_date] => published [show_pagination] => 2 [show_pagination_results] => 1 [show_feed_link] => 1 [feed_summary] => 0 [feed_show_readmore] => 0 [show_page_title] => 1 [secure] => 0 [show_page_heading] => 0 [page_title] => Strategies and Policies [page_description] => Hepatitis Queensland [page_rights] => [robots] => [page_heading] => Strategies and Policies ) ) [filter.published] => 1 [filter.archived] => 2 [filter.language] => ) [event_clean_cache:protected] => onContentCleanCache [_errors:protected] => Array ( ) ) ) [_basePath:protected] => /home/hepqld/public_html/components/com_content [_defaultModel:protected] => article [_layout:protected] => default [_layoutExt:protected] => php [_layoutTemplate:protected] => _ [_path:protected] => Array ( [template] => Array ( [0] => /home/hepqld/public_html/templates/if_960_j25/html/com_content/article/ [1] => /home/hepqld/public_html/components/com_content/views/article/tmpl/ ) [helper] => Array ( [0] => /home/hepqld/public_html/components/com_content/helpers/ ) ) [_template:protected] => /home/hepqld/public_html/templates/if_960_j25/html/com_content/article/default.php [_output:protected] => [_escape:protected] => htmlspecialchars [_charset:protected] => UTF-8 [_errors:protected] => Array ( ) [baseurl] => [document] => JDocumentHTML Object ( [_links] => Array ( ) [_custom] => Array ( ) [template] => [baseurl] => [params] => [_file] => [_template:protected] => [_template_tags:protected] => Array ( ) [_caching:protected] => [title] => Strategies and Policies [description] => Hepatitis Queensland [link] => [base] => http://hepqld.asn.au/information/strategies-and-policies [language] => en-gb [direction] => ltr [_generator] => Joomla! - Open Source Content Management [_mdate] => [_tab] => [_lineEnd] => [_charset] => utf-8 [_mime] => text/html [_namespace] => [_profile] => [_scripts] => Array ( [/media/system/js/mootools-core.js] => Array ( [mime] => text/javascript [defer] => [async] => ) [/media/system/js/core.js] => Array ( [mime] => text/javascript [defer] => [async] => ) [/media/system/js/caption.js] => Array ( [mime] => text/javascript [defer] => [async] => ) ) [_script] => Array ( [text/javascript] => window.addEvent('load', function() { new JCaption('img.caption'); }); ) [_styleSheets] => Array ( ) [_style] => Array ( ) [_metaTags] => Array ( [http-equiv] => Array ( [content-type] => text/html ) [standard] => Array ( [keywords] => Hepatitis Queensland [rights] => [author] => Hepatitis Admin ) ) [_engine] => [_type] => html [_errors:protected] => Array ( ) ) [pageclass_sfx] => )

Strategies and Policies

 

2014
 

National Hep C Strategy

The Fourth National Hepatitis C Virus (HCV) Strategy 2014-2017. This is one of five strategies aiming to reduce sexually transmissible infections (STI) and blood borne viruses (BBV), and the morbidity, mortality and personal and social impacts they cause. Developed by the Commonwealth of Australia.

2014
 

National Hep B Strategy

The Second National Hepatitis B Strategy 2014-2017. Developed by the Commonwealth of Australia.

2014
 

National Aboriginal Torres Strait Islander Blood Borne Virus Strategy

The Fourth National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2014-2017. Developed by the Commonwealth of Australia.

2010
 

National Hep C Strategy - 110KB PDF

Third National Hepatitis C Strategy 2010-2013.  This is the third national hep C strategy to be adopted in Australia. It builds on two previous strategies which guided Australia’s response to hep C between 1999 and 2008. Developed by the Commonwealth Department of Health and Ageing.

2010
 

National Hep B Strategy - 80KB PDF

National Hepatitis B Strategy 2010-2013. This is the first hep B strategy to be adopted in Australia. Developed by the Commonwealth Department of Health and Ageing.

2010
 

National Aboriginal Torres Strait Islander Blood Borne Virus Strategy - 150KB PDF

Third National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy 2010–2013. The third National Aboriginal and Torres Strait Islander Strategy dealing with blood borne viruses and sexually transmissible infections (STIs) to be adopted in Australia.

2010  

Hepatitis C Models of Access and Service Delivery for People with a History of Injecting Drug Use - 804KB PDF

"Research evidence reflects that in Australia unsafe injecting practices account for almost 80 percent of all current hepatitis C infections and over 90 percent of all new infections (Razali, 2007). While this evidence highlights the importance of focusing on strategies to prevent the further transmission of hepatitis C among people who inject drugs, the high rates of current infection also emphasise the urgent need to focus on the development of appropriate models of access and service delivery for people with hepatitis C and a history of injecting drug use. The need for more appropriate and targeted models of access and service delivery is further highlighted by the fact that 75 percent of people infected with hepatitis C will develop chronic infection (NCHECR, 2009a)." By Australian Injecting and Illicit Drug Users League (AIVL) October 2010.

2009  

 Strategic Directions for HIV/AIDS, Hepatitis C and Sexual Health 2009 - 2012 - 557KB  PDF

This document identifies priority actions for addressing HIV, HCV and STIs between 2009-2012. Published by Queensland Health.

2008
 

Guidelines for hep C prevention, treatment and care in Australian prisons - 300KB PDF

Hepatitis C Prevention, Treatment and Care: Guidelines for Australian Custodial Settings. These Guidelines and their Evidence-Base have been developed by the Prisons Working Group of the Hepatitis C Subcommittee of the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis (MACASHH) for the prevention, treatment and care of hepatitis C in custodial settings. The guiding principles for this document have been adopted from the National Hepatitis C Strategy 2005-2008.  

 
2008
 

Guidelines for hep C prevention, treatment and care in Australian prisons (the evidence base) - 300KB PDF

Hepatitis C Prevention, Treatment and Care: Guidelines for Australian Custodial Settings: Evidence base for the guidelines. This document explains the evidence base for the guidelines for the prevention, treatment and care of hepatitis C in custodial settings. It has been developed, at the same time as the guidelines, by the Prisons Working Group of the Hepatitis C Subcommittee of the Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis. 

 
2007  

Hepatitis Council of Queensland Strategic Plan 2007-2010 - 327KB PDF

Published by Hepatitis Queensland (previously the Hepatitis Council of Queensland), this document outlines HQ's 2007-2010 plan to 'provide holistic, innovative and pro-active responses to the challenges confronting people directly and indirectly affected by viral hepatitis'.

2007
 

National Hepatitis C Testing Policy - 300KB PDF

National Hepatitis C Testing Policy. Published by the Commonwealth Department of Health & Ageing Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis, and the Australian Population Health Development Principal Committee. This document provides policy on testing for hepatitis C,  monitoring the clinical condition of people before, during and after treatment for hepatitis C and screening the blood supply.

2006
 

Hepatitis B in Australia - 2MB PDF

Hepatitis B in Australia: responding to a diverse epidemic. Published by ACT-HBV, this report was authored by Greg Dore, Jack Wallace and others. This document aims to raise public awareness of hepatitis B, develop advocacy for a national strategy and provide a platform for developing a concerted public health approach to hepatitis B.

2005  

Queensland HIV, Hepatitis C and Sexually Transmissible Infections Strategy 2005–2011 - 858KB PDF

"The purpose of the Strategy is to provide direction and a framework for cooperation and support for and between government and non-government agencies, private practitioners, research organisations, service providers, community groups and the wider community to work together to: reduce the transmission of HIV, HCV and STIs, minimise the impact of HIV, HCV and STIs on the Queensland population; and improve the health and wellbeing of people living with HIV, HCV and STI-related chronic illness." Published by Queensland Health.

Some info republished here with permission from Hepatitis NSW.


 

© copyright 2013 | All Rights Reserved | Website design Brisbane by iFactory